Sprycel (dasatinib tablets - Bristol-Myers Squibb; generic) — Cigna

Initial criteria

• Approve for 1 year if ONE of the following (A or B) is met:
• A) Patient has Philadelphia chromosome-positive acute lymphoblastic leukemia; OR
• B) Patient has ABL-class translocation.

Approval duration

1 year